Lindus Health raises $6m from backers including Peter Thiel, Firstminute, and Seedcamp to accelerate clinical trials.
The London-based clinical trials platform has secured $6m to date from high-profile investors.
Lindus Health runs faster end-to-end clinical trials using its proprietary technology platform and machine learning. The firm operates across the UK, US and Europe to help bring treatments for chronic conditions to patients more quickly.
London-based Lindus Health has raised $6m in funding from backers including Firstminute Capital, Seedcamp, and Peter Thiel to advance its machine learning capabilities. The capital will also support the company in scaling its clinical trial technology platform, which aims to deliver medical treatments to patients faster than standard industry methods.
The latest financing follows a series of operational milestones for the start-up, which has already completed over 80 trials across multiple regions. Lindus Health is also supported by a grant from Innovate UK to further develop its data science applications in clinical research.
From the founder
"Clinical trials are the biggest bottleneck to improving human health. We’re working with high-growth companies developing the next wave of breakthrough treatments to accelerate the clinical trials process."
Michael Young
Co-Founder at Lindus Health
Use of funds
- 01Fund research and development
Investors
Categories
About the company
Lindus Health
Lindus Health operates a technology platform to run faster end-to-end clinical trials.